Bill > S868

This bill enhances health care market oversight and pharmaceutical access through a comprehensive set of reforms affecting various aspects of the healthcare system. The bill introduces several key provisions, including creating a new prescription drug cost assistance program that will provide financial support for individuals with certain chronic conditions, establishing stricter oversight and reporting requirements for pharmaceutical manufacturing companies and pharmacy benefit managers, and implementing new regulations for health care providers and private equity investments in healthcare. The legislation requires pharmaceutical companies to provide early notice about new drugs and significant price increases, mandates that pharmacy benefit managers pass 100% of drug rebates to health plans, and creates a new trust fund to help residents afford prescription drugs. Additionally, the bill strengthens the Health Policy Commission's ability to monitor healthcare costs, introduces more transparent pricing mechanisms, and adds protections for healthcare providers against inappropriate management interventions. The bill also includes provisions for continuous glucose monitoring systems and diabetes treatment supplies, ensuring these critical healthcare technologies are more accessible and affordable. These reforms aim to increase transparency, reduce healthcare costs, and improve patient access to essential medical services and medications.

Health and Social Services

https://malegislature.gov/Bills/194/S868